Pharma Stock Falls Amid Workforce Reduction Plans

The stock hit a 13-year low last month

Laura McCandless

Deputy Editor

Jan 9, 2023 at 10:30 AM

Emergent BioSolutions Inc (NYSE:EBS) is in the news today, after the pharmaceutical company announced it was cutting its workforce by roughly 5%. The move, along with other cost reduction measures, will save over $60 million in annual expenses.

EBS has reversed its premarket gains, however, and was down 5.2% at $12.87 at last glance. The security sports a 73.2% year-over-year deficit, but had been moving steadily higher since its Dec. 22, 13-year low of $10.61. A short-term drop could be in the cards, however, as the stock's 14-day relative strength index (RSI) of 84.5 sits in "overbought" territory.

Of the five analysts in coverage, four sport a "hold" rating, with one a "strong buy." Meanwhile, short interest has been on the rise, and represents 7.7% of the stock's available float, or nearly four days' worth of pent-up buying power.

Follow @Schaeffers

The $25K Day Trading Barrier is Gone

The long-standing Pattern Day Trader (PDT) rule that required many traders to maintain a $25,000 account balance is no longer standing in the way.

That means more traders can actively pursue short-term opportunities without the barrier that kept so many on the sidelines.

Now it's all about having the right strategy.

Dynamite Day Trading Signals helps you hit the ground running with up 2 options trade alerts per week, built to capture fast-moving opportunities.

👉 Sign up now to receive the next trade